Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.3.0.814
CONSOLIDATED STATEMENTS OF CASH FLOWS
BRL in Millions, $ in Millions
 9 Months Ended
Sep. 30, 2015
USD ($)
Sep. 30, 2014
USD ($)
Operating activities:    
Consolidated net income $ 321.8 $ 275.2
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Cost-method Investments, Other than Temporary Impairment 14.8 0.0
Depreciation and amortization 150.4 153.2
Stock-based compensation expense 32.2 29.0
Excess tax benefits from stock-based compensation plans (22.1) (11.9)
Deferred income taxes (24.3) 0.5
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (29.0) (11.1)
Prepaid expenses and other current assets 21.2 (36.6)
Other assets 3.9 (1.0)
Current liabilities, excluding debt 68.0 10.8
Other long-term liabilities, excluding debt (0.1) 5.3
Cash provided by operating activities 536.8 413.4
Investing activities:    
Capital expenditures (93.6) (63.9)
Acquisitions, net of cash acquired (4.4) (333.7)
Proceeds from Divestiture of Businesses 2.9 0.6
Investment in unconsolidated affiliates, net (0.1) (2.5)
Cash used in investing activities (95.2) (399.5)
Financing activities:    
Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less (193.4) 132.3
Repayments of Long-term Debt 0.0 (15.0)
Treasury stock purchases (196.3) (186.6)
Dividends paid to Equifax shareholders (103.4) (91.3)
Dividends paid to noncontrolling interests (6.0) (7.7)
Proceeds from exercise of stock options 26.0 29.7
Excess tax benefits from stock-based compensation plans 22.1 11.9
Other 0.0 0.0
Cash used in financing activities (451.0) (126.7)
Effect of foreign currency exchange rates on cash and cash equivalents (10.4) (8.1)
Decrease in cash and cash equivalents (19.8) (120.9)
Cash and cash equivalents, beginning of period 128.3 235.9
Cash and cash equivalents, end of period $ 108.5 $ 115.0